Medicine and Dentistry
Patient
100%
Adult
62%
Acute B-Cell Lymphoblastic Leukemia
62%
Chimeric Antigen Receptor T-Cell Immunotherapy
33%
Donor
33%
B-Cell Chronic Lymphocytic Leukemia
31%
Minimal Residual Disease
31%
Myeloproliferative Neoplasm
31%
Pediatrics
31%
Diagnosis
31%
Real-Time Polymerase Chain Reaction
31%
Assay
31%
Therapeutic Procedure
29%
Disease
12%
Progressive Disease
10%
Child
9%
Prognosis
8%
Morphology
8%
Transplantation
7%
Cytopenia
6%
Infection
6%
Clinical Feature
6%
Lymphadenopathy
6%
Hepatosplenomegaly
6%
Fitness
6%
Malaise
6%
Anemia
6%
Incidental Finding
6%
Diagnostic Test
6%
Target Cell
6%
Lymphocytosis
6%
Recurrent Infection
6%
Cell Signaling Pathway
6%
Supportive Care
6%
Immune Disorder
6%
Early Intervention
6%
Allogeneic Hematopoietic Stem Cell Transplantation
6%
Biological Marker
6%
Chemotherapy
6%
Chimeric Antigen Receptor T-Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myeloproliferative Neoplasm
31%
Antileukemic Agent
29%
Clinical Trial
27%
Chemotherapy
15%
Graft Versus Host Reaction
9%
Neurotoxicity
5%
Leukemia
5%
Immunology and Microbiology
Leukemia Cell
31%
B Cell
31%
Chimeric Antigen Receptor T-Cell Therapy
6%
Graft-Versus-Host Disease
6%
Stem Cell Transplant
6%
Lymphoid Tissue
5%